A binding factor for interleukin 2 mRNA.
AUTOR(ES)
Hua, J
RESUMO
Jurkat cells, a human T lymphocyte line that can be induced to synthesize and secrete interleukin 2, contain a factor that binds interleukin 2 mRNA. Binding can be demonstrated by formation of a complex detectable by gel electrophoresis. The binding is sequence specific and occurs in the 3'-non-coding region, within 160 nt of the end of the coding region, at or near a site on the mRNA that is rich in A and U residues. However, it appears not to be due to known AU binding factors. The factor is protease sensitive and binds non-covalently to interleukin 2 mRNA. It behaves like a protein of molecular weight 50 000-60 000 after UV-induced cross-linking to the mRNA. Preparations of the binding factor also protect interleukin 2 mRNA against degradation by a recently described RNasin-resistant endoribonuclease activity in Jurkat cells. Protection occurs under the same conditions required to generate the gel-retarded complex.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=145722Documentos Relacionados
- An RNasin-resistant ribonuclease selective for interleukin 2 mRNA.
- 2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA.
- HTLV-1 p27rex stabilizes human interleukin-2 receptor alpha chain mRNA.
- PDA1 mRNA: a standard for quantitation of mRNA in Saccharomyces cerevisiae superior to ACT1 mRNA.
- Polyadenylation sites for influenza virus mRNA.
